The market for Magnetic Resonance Imaging (MRI) Systems Market is expected to reach US$ XX Bn by 2022.
Imaging technologies such as X-ray, CT, ultrasound, and MRI are the most common imaging modules used for diagnostics and other practices. Among these technologies, magnetic resonance imaging (MRI) is increasingly becoming the most preferred imaging module due to the offered advantages such as image precision, accuracy, and minimum hazards from radiation exposure. In addition, MRI imaging can also produce 3D isotropic images and efficiently deliver soft tissue images, thus adding to the popularity of this technology in the global market.
The global MRI systems market is driven by growing awareness about the benefits of MRI, technological innovations, thus delivering precise imaging, and demand for high field scans. This technology is rapidly gaining a foothold in emerging markets of China, India, the Middle East, and Latin America due to the high prevalence of chronic conditions such as cancer, cardiovascular diseases, musculoskeletal conditions, and neurological conditions. Considering such potential opportunities, international players are gradually establishing their bases in these regions to enhance their revenue generation and geographic reach. However, unfavorable reimbursement for the latest technologies and a lack of skilled radiologists may hold back the growth of the MRI systems industry in developed markets.
System Type
Applications
Architecture
Geography
Key players identified in magnetic resonance imaging (MRI) systems market include but are not limited to: GE Healthcare, Hitachi Medical Corporation, Philips Healthcare, Siemens Healthcare, Toshiba Medical Systems, Neusoft Medical Systems Co., Ltd., and others
The market for Magnetic Resonance Imaging (MRI) Systems Market is expected to reach US$ XX Bn by 2022.
The Magnetic Resonance Imaging (MRI) Systems Market is expected to see significant CAGR growth over the coming years, at XX%.
The report is forecasted from 2020.
The base year of this report is 2021.